CID 135566439
N-{3-[5-hydroxy-2-(3-methylbutyl)-3-oxo-6-pyrrolidin-1-yl-2,3-dihydropyridazin-4-yl]-1,1-dioxido-2h-1,2,4-benzothiadiazin-7-yl}methanesulfonamide
Structural Information
- Molecular Formula
- C21H28N6O6S2
- SMILES
- CC(C)CCN1C(=O)C(=C(C(=N1)N2CCCC2)O)C3=NS(=O)(=O)C4=C(N3)C=CC(=C4)NS(=O)(=O)C
- InChI
- InChI=1S/C21H28N6O6S2/c1-13(2)8-11-27-21(29)17(18(28)20(23-27)26-9-4-5-10-26)19-22-15-7-6-14(24-34(3,30)31)12-16(15)35(32,33)25-19/h6-7,12-13,24,28H,4-5,8-11H2,1-3H3,(H,22,25)
- InChIKey
- QUWPELVBLLLYGL-UHFFFAOYSA-N
- Compound name
- N-[3-[5-hydroxy-2-(3-methylbutyl)-3-oxo-6-pyrrolidin-1-ylpyridazin-4-yl]-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazin-7-yl]methanesulfonamide
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 525.15848 | 216.4 |
[M+Na]+ | 547.14042 | 223.9 |
[M-H]- | 523.14392 | 217.9 |
[M+NH4]+ | 542.18502 | 219.3 |
[M+K]+ | 563.11436 | 216.9 |
[M+H-H2O]+ | 507.14846 | 209.7 |
[M+HCOO]- | 569.14940 | 217.0 |
[M+CH3COO]- | 583.16505 | 238.6 |
[M+Na-2H]- | 545.12587 | 217.2 |
[M]+ | 524.15065 | 219.5 |
[M]- | 524.15175 | 219.5 |